C61
Conditions
Interventions
Group 1: - Retrospective evaluation of the medical records from the AIS of the urology practice PROURO Berlin and from the KIS of the University Clinic for Urology Magdeburg:
o PSA initial
o DRE
o Pro
Sponsors
Universitätsklinik für Urologie, Uroonkologie, robotergestützte und fokale Therapie
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Consultation as part of the early detection examination or to check findings in case of suspicious findings in the conventional screening tests (PSA, DRE, TRUS)
Exclusion criteria
Exclusion criteria: no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MicroUS of the prostate in screening is equivalent to screening with PSA, biopsy, and MRI. Determination of sensitivity, specificity, negative and positive predictive value of MicroUS | — |
Secondary
| Measure | Time frame |
|---|---|
| - How many patients had prostate cancer despite a negative microUS? - How many patients had clinically significant prostate cancer despite a negative microUS? - How many patients did not have prostate cancer despite a positive microUS? - How many MRIs and biopsies could have been avoided if the microUS had been correctly negative? | — |
Countries
Germany
Contacts
Public ContactJohann Wendler
Praxis für Urologie Magdeburg Urologen am Hasselbachplatz
Outcome results
None listed